120 related articles for article (PubMed ID: 12470423)
1. Sensitivity of model-based calculations of red marrow dosimetry to changes in patient-specific parameters.
Stabin MG; Siegel JA; Sparks RB
Cancer Biother Radiopharm; 2002 Oct; 17(5):535-43. PubMed ID: 12470423
[TBL] [Abstract][Full Text] [Related]
2. Red marrow radiation dose adjustment using plasma FLT3-L cytokine levels: improved correlations between hematologic toxicity and bone marrow dose for radioimmunotherapy patients.
Siegel JA; Yeldell D; Goldenberg DM; Stabin MG; Sparks RB; Sharkey RM; Brenner A; Blumenthal RD
J Nucl Med; 2003 Jan; 44(1):67-76. PubMed ID: 12515878
[TBL] [Abstract][Full Text] [Related]
3. Use of Monte Carlo simulations with a realistic rat phantom for examining the correlation between hematopoietic system response and red marrow absorbed dose in Brown Norway rats undergoing radionuclide therapy with (177)Lu- and (90)Y-BR96 mAbs.
Larsson E; Ljungberg M; Martensson L; Nilsson R; Tennvall J; Strand SE; Jonsson BA
Med Phys; 2012 Jul; 39(7):4434-43. PubMed ID: 22830776
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
[TBL] [Abstract][Full Text] [Related]
5. Influence of total-body mass on the scaling of S-factors for patient-specific, blood-based red-marrow dosimetry.
Traino AC; Ferrari M; Cremonesi M; Stabin MG
Phys Med Biol; 2007 Sep; 52(17):5231-48. PubMed ID: 17762083
[TBL] [Abstract][Full Text] [Related]
6. Correlation of red marrow radiation dosimetry with myelotoxicity: empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings.
Behr TM; Béhé M; Sgouros G
Cancer Biother Radiopharm; 2002 Aug; 17(4):445-64. PubMed ID: 12396708
[TBL] [Abstract][Full Text] [Related]
7. Contribution to red marrow absorbed dose from total body activity: a correction to the MIRD method.
Stabin MG; Siegel JA; Sparks RB; Eckerman KF; Breitz HB
J Nucl Med; 2001 Mar; 42(3):492-8. PubMed ID: 11337528
[TBL] [Abstract][Full Text] [Related]
8. Improved prediction of myelotoxicity using a patient-specific imaging dose estimate for non-marrow-targeting (90)Y-antibody therapy.
Shen S; Meredith RF; Duan J; Macey DJ; Khazaeli MB; Robert F; LoBuglio AF
J Nucl Med; 2002 Sep; 43(9):1245-53. PubMed ID: 12215566
[TBL] [Abstract][Full Text] [Related]
9. Practical determination of patient-specific marrow dose using radioactivity concentration in blood and body.
Shen S; DeNardo GL; Sgouros G; O'Donnell RT; DeNardo SJ
J Nucl Med; 1999 Dec; 40(12):2102-6. PubMed ID: 10616892
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy.
Hindorf C; Lindén O; Tennvall J; Wingårdh K; Strand SE
Acta Oncol; 2005; 44(6):579-88. PubMed ID: 16165917
[TBL] [Abstract][Full Text] [Related]
11. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
12. A compartmental model of mouse thrombopoiesis and erythropoiesis to predict bone marrow toxicity after internal irradiation.
Sas N; Rousseau J; Nguyen F; Bellec E; Larrsson E; Becavin S; Hindorf C; Abadie J; Chouin N; Barbet J
J Nucl Med; 2014 Aug; 55(8):1355-60. PubMed ID: 24935991
[TBL] [Abstract][Full Text] [Related]
13. Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibody.
Siegel JA; Pawlyk DA; Lee RE; Sasso NL; Horowitz JA; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):1039s-1042s. PubMed ID: 2297717
[TBL] [Abstract][Full Text] [Related]
14. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
DeNardo GL; Siantar CL; DeNardo SJ
Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
[TBL] [Abstract][Full Text] [Related]
15. Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.
Siegel JA
Cancer Biother Radiopharm; 2005 Apr; 20(2):126-40. PubMed ID: 15869446
[TBL] [Abstract][Full Text] [Related]
16. Absorbed fractions for alpha-particles in tissues of trabecular bone: considerations of marrow cellularity within the ICRP reference male.
Watchman CJ; Jokisch DW; Patton PW; Rajon DA; Sgouros G; Bolch WE
J Nucl Med; 2005 Jul; 46(7):1171-85. PubMed ID: 16000287
[TBL] [Abstract][Full Text] [Related]
17. Dosimetry considerations of bone-seeking radionuclides for marrow ablation.
Bayouth JE; Macey DJ
Med Phys; 1993; 20(4):1089-96. PubMed ID: 8413017
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
19. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
Pahlka RB; Sonnad JR
Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
[TBL] [Abstract][Full Text] [Related]
20. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
